These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 37955136)

  • 1. Advances in adrenergic receptors for the treatment of chronic obstructive pulmonary disease: 2023 update.
    Matera MG; Rinaldi B; Calzetta L; Rogliani P; Cazzola M
    Expert Opin Pharmacother; 2023; 24(18):2133-2142. PubMed ID: 37955136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of β2-adrenergic receptors in chronic obstructive pulmonary disease.
    Yang A; Yu G; Wu Y; Wang H
    Life Sci; 2021 Jan; 265():118864. PubMed ID: 33301808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of a novel class of inhaled dual pharmacology muscarinic antagonist and β
    Rancati F; Linney ID; Rizzi A; Delcanale M; Knight CK; Schmidt W; Pastore F; Riccardi B; Mileo V; Carnini C; Cesari N; Blackaby WP; Patacchini R; Carzaniga L
    Bioorg Med Chem Lett; 2021 Jun; 41():127975. PubMed ID: 33753262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Divergent agonist selectivity in activating β1- and β2-adrenoceptors for G-protein and arrestin coupling.
    Casella I; Ambrosio C; Grò MC; Molinari P; Costa T
    Biochem J; 2011 Aug; 438(1):191-202. PubMed ID: 21561432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent Advances in β
    Xing G; Woo AY; Pan L; Lin B; Cheng MS
    J Med Chem; 2020 Dec; 63(24):15218-15242. PubMed ID: 33213146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent progress in the development of β2 adrenergic receptor agonists: a patent review (2015-2020).
    Xing G; Yi C; Dou P; Zhi Z; Lin B; Cheng M
    Expert Opin Ther Pat; 2021 Mar; 31(3):239-246. PubMed ID: 33320034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. β2-Adrenoceptor signalling bias in asthma and COPD and the potential impact on the comorbidities associated with these diseases.
    Matera MG; Page C; Rinaldi B
    Curr Opin Pharmacol; 2018 Jun; 40():142-146. PubMed ID: 29763833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and characterization of pepducins as Gs-biased allosteric agonists.
    Carr R; Du Y; Quoyer J; Panettieri RA; Janz JM; Bouvier M; Kobilka BK; Benovic JL
    J Biol Chem; 2014 Dec; 289(52):35668-84. PubMed ID: 25395624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Research and development of bronchodilators for asthma and COPD with a focus on G protein/KCa channel linkage and β2-adrenergic intrinsic efficacy.
    Kume H; Fukunaga K; Oguma T
    Pharmacol Ther; 2015 Dec; 156():75-89. PubMed ID: 26432616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro anti-inflammatory effects of AZD8999, a novel bifunctional muscarinic acetylcholine receptor antagonist /β2-adrenoceptor agonist (MABA) compound in neutrophils from COPD patients.
    Milara J; Contreras S; de Diego A; Calbet M; Aparici M; Morcillo E; Miralpeix M; Cortijo J
    PLoS One; 2019; 14(1):e0210188. PubMed ID: 30608978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of Allosteric Effect and K
    Kume H; Nishiyama O; Isoya T; Higashimoto Y; Tohda Y; Noda Y
    Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 29987243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. β
    De Pascali F; Ippolito M; Wolfe E; Komolov KE; Hopfinger N; Lemenze D; Kim N; Armen RS; An SS; Scott CP; Benovic JL
    Br J Pharmacol; 2022 Oct; 179(19):4692-4708. PubMed ID: 35732075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tyrosine 308 is necessary for ligand-directed Gs protein-biased signaling of β2-adrenoceptor.
    Woo AY; Jozwiak K; Toll L; Tanga MJ; Kozocas JA; Jimenez L; Huang Y; Song Y; Plazinska A; Pajak K; Paul RK; Bernier M; Wainer IW; Xiao RP
    J Biol Chem; 2014 Jul; 289(28):19351-63. PubMed ID: 24831005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GS-5759, a Bifunctional β2-Adrenoceptor Agonist and Phosphodiesterase 4 Inhibitor for Chronic Obstructive Pulmonary Disease with a Unique Mode of Action: Effects on Gene Expression in Human Airway Epithelial Cells.
    Joshi T; Yan D; Hamed O; Tannheimer SL; Phillips GB; Wright CD; Kim M; Salmon M; Newton R; Giembycz MA
    J Pharmacol Exp Ther; 2017 Feb; 360(2):324-340. PubMed ID: 27927912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta2- and beta3-adrenoceptors activate glucose uptake in chick astrocytes by distinct mechanisms: a mechanism for memory enhancement?
    Hutchinson DS; Summers RJ; Gibbs ME
    J Neurochem; 2007 Nov; 103(3):997-1008. PubMed ID: 17680985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. THRX-198321 is a bifunctional muscarinic receptor antagonist and beta2-adrenoceptor agonist (MABA) that binds in a bimodal and multivalent manner.
    Steinfeld T; Hughes AD; Klein U; Smith JA; Mammen M
    Mol Pharmacol; 2011 Mar; 79(3):389-99. PubMed ID: 21139051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of (a Combination of) the Beta
    Maarsingh H; Oldenburger A; Han B; Zuidhof AB; Elzinga CRS; Timens W; Meurs H; Sopi RB; Schmidt M
    Cells; 2021 May; 10(5):. PubMed ID: 34069899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Long-Acting Muscarinic Antagonist/Long-Acting β
    Petite SE
    Ann Pharmacother; 2017 Aug; 51(8):696-705. PubMed ID: 28410560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overuse of long-acting β
    Brunton SA; Hogarth DK
    Postgrad Med; 2023 Nov; 135(8):784-802. PubMed ID: 38032494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. β-blockers Reverse Agonist-Induced β
    Maccari S; Vezzi V; Barbagallo F; Stati T; Ascione B; Grò MC; Catalano L; Marano G; Matarrese P; Ambrosio C; Molinari P
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31947522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.